Replies to post #450291 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

XenaLives

I'd rather see AVXL as a dominant entity in drugs that treat CNS and other disease on a molecular level.

...


OK w/me....BUT ...but (in my VERY LIMITED thinking) AVXL is leading an awakening-discovery process in CNS BIO-Med diseases causal links. I am not Bio-qualified to define/describe the discovery process but I have seen such in my past in semiconductor device physics development physics-engineering. In fact after 40+ years that learning process is still evolving. IMO, the same principals or /+/- new learning apply here also. The big difference is semiconductors present a harder science (trial-error certainty) vs medical-bio learning fields of unknown-unproven variables. FDA needs to refine that model and help everyone to move on for the sake of humanity, IMO.

I do agree that AVXL is presenting the brightest CNS diseases light (by far) .